Your browser doesn't support javascript.
loading
[Efficacy and safety of narlaprevir/ritonavir and daclatasvir non interferon combination in population of Russian patients with chronic hepatitis C].
Klimova, E A; Burnevich, E Z; Chulanov, V P; Gusev, D A; Znoyko, O O; Batskikh, S N; Kizlo, S N; Mamonova, N A; Tarkhova, E P; Krasavina, E N; Samsonov, M Y; Yushchuk, N D.
Afiliación
  • Klimova EA; Yevdokimov Moscow State University of Medicine and Dentistry.
  • Burnevich EZ; Sechenov First Moscow State Medical University (Sechenov University).
  • Chulanov VP; City Clinical Hospital №24.
  • Gusev DA; Sechenov First Moscow State Medical University (Sechenov University).
  • Znoyko OO; Central Research Institute of Epidemiology.
  • Batskikh SN; Centre for the Prevention and Control of AIDS and Infectious Diseases.
  • Kizlo SN; Yevdokimov Moscow State University of Medicine and Dentistry.
  • Mamonova NA; Central Research Institute of Epidemiology.
  • Tarkhova EP; Centre for the Prevention and Control of AIDS and Infectious Diseases.
  • Krasavina EN; Central Research Institute of Epidemiology.
  • Samsonov MY; R-Pharm.
  • Yushchuk ND; R-Pharm.
Ter Arkh ; 91(8): 67-74, 2019 Aug 15.
Article en Ru | MEDLINE | ID: mdl-32598756
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Ritonavir / Hepatitis C Crónica / Imidazoles Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Asia / Europa Idioma: Ru Revista: Ter Arkh Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antivirales / Ritonavir / Hepatitis C Crónica / Imidazoles Límite: Adult / Female / Humans / Middle aged País/Región como asunto: Asia / Europa Idioma: Ru Revista: Ter Arkh Año: 2019 Tipo del documento: Article